Skip to content

  • Home
  • About
  • Custom Aptamers
    • Aptamer Selection
    • NGS Analysis
    • Binding Assays
    • Other Aptamer Services
  • News
  • Resources
    • What is an aptamer?
    • FAQs
    • Videos
  • Contact Us
Uncategorized

Aptamer for Covid-19 under development

Posted April 21, 2020October 21, 2020 NeoVentures

 

NeoVentures is developing an aptamer for SARS-CoV-2. This aptamer will be fully characterized with sequence structure and binding coefficients. Contact us at info@neoventures.ca for licensing terms.

Post navigation

⟵Successful development of a breast cancer cell Aptasensor with our HER2 aptamer( HeA2_3)
  • Youtube
  • LinkedIn
  • email
Proudly powered by WordPress | Theme: Sydney by aThemes.